Teladoc Health is the largest telehealth company in the US. It has a platform that offers 24-hour on-demand healthcare services via the internet as well as mobile devices. The company generates a majority of its revenue from a subscription model, which brings in recurring payments. More than 40% of the Fortune 500 are clients of Teladoc. Telemedicine is poised to grow rapidly in a post-pandemic world. This trend, combined with Teladoc’s extensive customer base, its large physician network, and its dominant market position, place the company well for long-term future growth.
Teladoc listed on the NYSE in July 2015. The monthly chart for Teladoc shows an uptrend since 2016. This uptrend reached its peak in early 2021 when the price crossed the highs of $300. However, starting February 2021, the price pulled back more than 50% and briefly breaking the bottom trend line. In June 2021, the downtrend seems to have reversed as the price bounced up from the bottom trend line. The likely target would now be a retest of the $300 highs. A stop-loss can be placed below the bottom trend line at $130.

Position entered into our long-term tracking portfolio today. The entry point is at $163.50, and stop-loss placed at $127.55, which is 22% below the entry point. The short-term to medium-term take profit at the top of the trend is set at $193.67, giving a profit of 18%.